The diagnostic accuracy of serologic markers in children with IBD: The West Virginia experience

Journal of Clinical Gastroenterology

Volumn 39, Issue 8, 2005, Pages 670-673

  Elitsur, Yoram ^a   Lawrence, Zandra ^a   Tolaymat, Naser ^b  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

ASCA; Children; IBD; pANCA

Indexed keywords

ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; OUTER MEMBRANE PROTEIN OMPC ANTIBODY; PERINUCLEAR NEUTROPHIL CYTOPLASMIC ANTIBODY; SACCHAROMYCES CEREVISIAE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ARTICLE; COLON RESECTION; CROHN DISEASE; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ESCHERICHIA COLI; ETHNOLOGY; FEMALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS; UNITED STATES;

ADOLESCENT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, FUNGAL; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFLAMMATORY BOWEL DISEASES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; WEST VIRGINIA;

EID: 23844510828     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000173853.78042.2d     Document Type: Article

References (21)

1. Gower-Roussseau C, Salomez JL, Dupas JL, et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut. 1994;35: 1433-1438.
2. Sandler RS. Epidemiology of inflammatory bowel disease. In: Targan SR, Shanahan F, eds. Inflammatory Bowel Disease: From Bench to Bench. Baltimore: Williams & Wilkins, 1993:5-30.
3. Evans CM, Beattie RM, Walker-Smith JA. Inflammatory bowel disease in childhood. In: Allan RN, Rhodes JM, Hanauer SB, et al, eds. Inflammatory Bowel Diseases, 3rd ed. New York: Churchill Livingstone, 1997: 647-670.
4. Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmatic antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998; 42:788-791.
5. Sendid B, Colombel JF, Jacquinot PM, et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol. 1996;3:219-226.
6. Peeters M, Joossens S, Vermeire S, et al. Diagnostic value of anti-saccharomyces cerevisiae and antineutrophil cytoplasmatic autoantibodies in inflammatory bowel disease. Am J Gastroenterol. 2001;96:730-734.
7. Khan K, Schwarzenberg SJ, Sharp HL, et al. Role of serology and routine laboratory tests in childhood inflammatory bowel disease. Inflamm Bowel Dis. 2002;8:325-329.
8. Proujansky R, Fawcett PT, Gibney KM, et al. Examination of ANCA in childhood IBD. J Pediatr Gastroenterol Nutr. 1993;17:193-I97.
9. Hoffenberg EJ, Fidanza S, Sauaia A. Serologic testing for IBD. J Pediatr. 1999;134:447-452.
10. Winter HS, Landers CJ, Winkelstein A, et al. Antineutrophil cytoplasmatic antibodies in children with ulcerative colitis. J Pediatr. 1994;125: 707-711.
11. Olives JP, Breton A, Hugo JP, et al. Antineutrophil cytoplasmatic antibodies in children with IBD: prevalence and diagnostic value. J Pediatr Gastroenterol Nutr. 1997;25:142-148.
12. Ruemmele FM, Targan SR, Levy G, et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology. 1998;115:822-829.
13. Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology. 2003;124:521-536.
14. Census Bureau US. [West Virginia Quick Facts web site]. Available http://quickfacts.census.gov/qfd/states/54000.html.
15. Singer D. American Jewish Year Book 2002 [Jewish Virtual Library web site]. Available at http//www.jewishvirtuallibrary.org/jsource/US-Israel/ usjewpop.html.
16. Vasiliauskas EA, Plevy SE, Landers CJ, et al. Perinuclear antineutrophil cytoplasmatic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterologe: 1996;110:1810-1819.
17. Satsangi J, Landers CJ, Welsh KI, et al. The presence of antineutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease. Inflamm Bowel Dis. 1998;4:18-26.
18. Vasiliauskas EA, Kam LY, Karp LC, et al. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut. 2000;47:487-496.
19. Targan SR. The utility of ANCA and ASCA in inflammatory bowel disease. Inflamm Bowel Dis. 1999;5:61-63.
20. Arnott IDR, Landers CJ, Elaine JN, et al. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol. 2004;99:2376-2384.
21. Mow WS, Vasiliauskas EA, Lin Y-C, et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology. 2004;126:414-424.